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Abstract
Objective: A serious complication of joint replacement surgery is infection, which results in prolonged invalidity as well as
removal and subsequent re-implantation after lengthy antibiotic therapy. In terms of diagnostic imaging, nuclear medicine has
presented several tracers and imaging modalities over the years to be used in prosthetic joint infection. The PubMed/MEDLINE
literature database was systematically examined for publications on infection, arthroplasty, joint replacement, prosthetic joint,
gallium, labeled leukocytes, sulfur colloid, antimicrobial peptides, Fluorine-18-fluorodeoxyglucose (18F-FDG), positron emission
tomography/computed tomography (PET-CT), and single-photon emission (SPET-CT). This was determined to be a
comprehensive review, not a meta-analysis of prosthetic joint infection and diagnostic imaging in the field of nuclear medicine.
Prosthetic joint replacement is more frequently being employed as a way of improving the quality of life in an ever-ageing
population. Complications following joint replacement surgery include aseptic or mechanical loosening, as well as polyethylene
wear and prosthetic joint infection. The rate of infection is estimated to be between 1%-3%. The therapeutic management of
these complications lies in the ability to differentiate between infection and aseptic mechanical loosening. Given that plain
radiographs are neither sensitive nor specific to infection and computer tomography, as well as magnetic resonance imaging are
limited due to metal-induced artifacts, radionuclide imaging has come to aid in the diagnostic imaging in the failed joint
replacement. However, each modality has its advantages and disadvantages, thus there is no gold standard technique of
radionuclide imaging. Nevertheless, radiolabelled leukocyte scintigraphy has proven itself to be the gold standard in neutrophilbased infection processes. Several studies have examined the role of PET using radiotracers such as 18F-FDG, gallium-67 and
18
F, as well as SPET-CT in diagnosing prosthetic joint infections. Other radiotracers, such as antigranulocyte antibodies and
fragments, as well as radiolabeled antibodies and antimicrobial peptide have yet to confirm their role in diagnostic imaging of the
failed joint replacement. Nuclear medicine plays a vital role in diagnosing prosthetic joint infections. WBC/bone marrow imaging
is the best available diagnostic imaging test. Newer imaging modalities, such as SPET-CT may in the future, play a larger role in
diagnosing prosthetic joint infections. The roles of 18F-PET and 18F-FDG-PET have yet to still be determined.
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Introduction

P

rosthetic joint replacement is being more frequently employed as a way of improving the quality of life in an everageing population, given that life expectancy is steadily increasing [1]. However, as with every surgical procedure,
there are certain risks and complications. Common complications following joint replacement surgery are aseptic or
mechanical loosening, as well as polyethylene wear [2]. While not often observed, prosthetic joint infection is a serious
complication that can result in significant morbidity, decrease in joint function, prolonged invalidity and hospitalization,
often leading to explantation and subsequent re-implantation following several weeks of antibiotic therapy [1, 3]. In
addition, the financial, clinical and psychological factors of such an infection must be taken into consideration [4]. There is
a 1% rate of infection following primary hip implantation and 2% for knee prostheses [5]. Following revision surgery, these
numbers increase to about 3% for hip replacements and 5% for knee replacements [5].
Prosthetic joint infections can be grouped into “early” (within three months after surgery), “delayed” (between
three months to two years) and “late” (after two years) [6]. The two most common organisms found are Staphylococcus
epidermidis (31%) and Staphylococcus aureus (20%) [2]. Whereas Staphylococcus aureus is typically isolated in “early”
infections, coagulase-negative Staphylococci, Streptococci, Enterococci and Anaerobes are seen in “late” infections [6].
Some factors that predispose individuals to prosthetic joint infections are higher age, obesity, underlying joint infection
(rheumatoid arthritis, psoriasis), poor nutritional status, diabetes mellitus, remote infection and prior joint infection, as well
as immune suppression [7, 8].
www.nuclmed.gr
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Between the patient’s bone and the prosthesis material is a thin layer of reactive fibrous tissue, also known as a
membrane [1]. In prosthetic joint infection, either as a result of microbial colonization that occurs at time of implantation or
haematogenous seeding leads to inflammatory cells, collagen and blood vessels thicken this membrane [1]. Furthermore,
the pathogens attach to the membrane by means of capsular polysaccharide-associated adhesins and a proteinaceous
cell wall, subsequently secreting a biofilm that protects them from the host immune response and antibiotics [1].
Therefore, diagnosis and subsequent treatment of joint infections are quite difficult.
It is a known fact that bacteria secrete chemotactic factors, such as histamine and prostaglandins that recruit
leukocytes, induce endothelial activation and cause edema. Therefore, the incessant recruitment of leukocytes from the
blood to the periprosthetic tissue is typical of acute or sub-acute bacterial infection. Due to active migration into an
infected tissue by means of adherence to vascular endothelium followed by migration, autologous radiolabelled white
blood cells have a high specificity [9]. A subtype of white blood cells (WBC), neutrophils, are present in the infected joint
and are the predominantly labeled circulating cell in labeled leukocyte scintigraphy (LS) with tracers, such as 111In-oxine
and 99m Tc-hexamethyl propyleneamine oxime (HMPAO) [1]. Leukocyte labeling in infection imaging was first introduced in
1976 by McAfee and Thakur [10]. Labeled leukocytes do not accumulate at sites absent of infection or where there is
increased bone turnover [1]. Therefore, LS is considered to be a valuable tool in diagnosing prosthetic joint infections [1].
In addition, given that neutrophils are typically absent in aseptic loosened prosthesis, LS should be able to distinguish
between an infected prosthesis and an inflamed aseptic prosthesis [5, 11, 12]. However, bone marrow displacement or
activation by surgery can result in a secondary uptake of leukocytes around prostheses [1]. Therefore, a combination of
LS and bone marrow scintigraphy (BMS) with 99m Tc-sulphur-/nanocolloid has been introduced [1]. Within 48 hours of
bacterial seeding, an acidic pH, low oxygen tension, increased intraosseous pressure and vascular insufficiency suppress
the uptake of sulfur-/nano colloid [13]. Given that infection stimulates the uptake of leukocytes, but suppresses the uptake
of sulfur-/nanocolloid, LS and BMS in infections are spatially incongruent [5]. If however, the uptake of the two
radiopharmaceuticals is similar or spatially congruent, the labeled leukocyte activity is attributable to bone marrow uptake
[5].
In terms of diagnostic imaging, nuclear medicine has offered various tracers and imaging modalities over the
years to be used in diagnosing infected joint replacements. This review will discuss those most widely used.

Preoperative work-up in suspected prosthetic infections
Prosthetic joint infection is defined by major and minor criteria. Major criteria include: a) presence of a sinus tract
communicating with the prosthesis or b) two positive periprosthetic cultures with phenotypically identical organisms [14].
Minor criteria include: 1) raised serum erythrocyte sedimentation rate (ESR) and serum C-reactive protein concentration
(CRP), 2) raised synovial WBC count change on leucocyte esterase test strip, 3) raised synovial polymorphonuclear
neutrophil percentage, 4) positive histological analysis of periprosthetic tissue or 5) a single positive culture [14]. One of
the most perplexing diagnostic situations involves a persistent marginally elevated CRP or tenacious pain after surgery
[1]. Therefore, diagnosis involves a variety of different factors. Firstly, thorough clinical histories, including medical,
surgical and physical examinations deliver excellent initial diagnostic and aid in subsequent diagnostic evaluation [1].
Further diagnostic evaluation of prosthetic joint infection includes hematological tests with inflammation markers (Creactive protein (CRP), WBC count, ESR and interleukin-6). A study by Glithero et al. (1993) [15] examining CRP values
in patients with suspected prosthetic infections reported a sensitivity, specificity and accuracy of 83%, 74%, and 77%,
respectively. In a study currently under review, the sensitivity of CRP was 57%, specificity 28%, with an overall accuracy
of 33% [16]. A review by Yuan et al. (2014) [17] demonstrated that CRP had good diagnostic accuracy for periprosthetic
infections with a sensitivity of 82% and specificity of 77%. Overall, it appears that CRP alone is not very accurate in
prosthetic joint infections. In terms of WBC count, a study by Berbari et al. (2010) [18] that demonstrated that WBC count
has the lowest diagnostic accuracy for prosthetic joint infections. While this analysis only investigated serum CRP and
WBC count, a study by Claassen et al. (2014) [19] that assessed 46 patients with knee arthroplasty and aspiration in 77
cases, demonstrated an increase in WBC count in only 7 cases and normal levels in the remaining patients. In addition,
CRP was increased in 33 cases and normal in 44 cases [19]. In a study currently under review, they demonstrated a
sensitivity of 0%, specificity of 92% and overall accuracy of 82% [16]. Similar to this study, Claassen et al. (2014) [19] also
concluded that CRP and WBC are not accurate in diagnosing ongoing infection.
A normal CRP or ESR cannot completely rule out a low-grade infection, given that false negative results can
occur following long-term antibiotic treatment or in patients with delayed-onset infection [18]. Therefore, additional
diagnostic examinations, such as joint aspiration with a WBC count and differential, gram stain and culture, as well as
numerous imaging modalities may be required [1, 18].

Well-established tracers in infection
67

Gallium-citrate
Gallium-67 (67Ga) is an analog of iron that can bind to circulating transferrin in its ionic form and thus uses transferrin
receptors to enter cells and become highly stable [20, 21]. Roughly 90% of 67Ga-citrate is transferrin-bound and found in
the plasma [22]. It is believed that 67Ga-citrate can seep through the vascular endothelium and attach to lactoferrin, which
is released by leukocytes or siderophores expelled by the infectious microorganisms at infection foci [23]. Given that the
siderophores have a high affinity for 67Ga, they readily bind and are transported into the microorganism, to later be
www.nuclmed.gr
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phagocytized by macrophages [24]. 67Ga is normally distributed within the liver, bone marrow, bone, soft tissues,
gastrointestinal- and genitourinary tracts [21, 24]. In the past, 67Ga has been used for accessing prosthetic joint infection.
The reported accuracy lies between 50% [25] and 95% [26]. Gomez-Luzuriaga et al. (1988) [27] demonstrated a
sensitivity, specificity and accuracy of 70%, 90% and 80%, respectively. Mountford et al. (1986) [28] and McKillop et al.
(1984) [29] also reported the accuracy of gallium scintigraphy in prosthetic joint infection to be 80%. Conversely, Kraemer
et al. (1993) [30] exhibited a low sensitivity of 38% but a high specificity of 100% and overall accuracy of 81%. In addition,
Aliabadi et al. (1989) [31] demonstrated a sensitivity of 37% and specificity of 100%. Merkel et al. (1986) [32] presented a
study showing 66% sensitivity, 81% specificity and 77% accuracy in 67Ga diagnostic testing of infection in the painful
prostheses. Similar results have been seen in 67Ga testing in animals. Merkel et al. (1984) [33] reported a sensitivity,
specificity and accuracy of 61%, 71% and 67%, respectively in loose and infected canine arthroplasty. While diagnostic
testing with 67Ga in prosthetic joint infections has been carried out at one time, its accuracy was not acceptable when
trying to determine an infected prosthetic joint from an inflamed one. It is now typically limited to diagnosing chronic
osteomyelitis, fever of unknown origin (FUO) and lung infections.
111

In-oxine
In-oxine is characterized by its ability to diffuse through the cell membrane and detach itself from the lipophilic complex,
thus leading to an irreversible binding to the nuclear and other intracellular components [21, 34]. Some advantages of
using 111In-oxine include a 67h half-life with a constant distribution limited to the bone marrow, liver and spleen, which is a
great benefit, especially in infections of the prosthetic joint and musculoskeletal system [22]. Disadvantages include not
being able to use this radiotracer in inflammatory bowel diseases, as well as a 24h-interval requirement between injection
and imaging [22]. The sensitivity of indium-111 LS lies within 38%-100%, specificity between 15%-100% and accuracy
60%-96% [15, 35-37]. However, in combination with technetium-99m sulfur colloid, it is possible to increase sensitivity,
specificity and accuracy. Mulamba et al. (1983) [38] demonstrated a sensitivity, specificity and accuracy of 92%, 100%
and 96%, respectively. Furthermore, Palestro et al. (1991) [39] exhibited a sensitivity of 86%, specificity of 97% and
accuracy of 95% in 41 patients with knee prostheses suspected of being infected. In addition, Palestro et al. (1990) [40]
reported a sensitivity, specificity and accuracy of 100%, 97% and 98%, respectively in 92 cemented total-hip
arthroplasties. Finally, a study by Joseph et al. (2001) [41] in 58 patients before reoperation of total knee or hip
arthroplasty demonstrated a sensitivity of 46%, specificity of 100% and overall accuracy of 88%. Typical indications of
using 111In-oxine include diagnostic imaging for prosthetic joint infections, chronic osteomyelitis and in certain cases of
fever of unknown origin/occult fever [23].
111

99m

Tc-hexamethylpropyleneamine oxine (HMPAO)
Labeling of leukocytes with 99mTc-HMPAO was first introduced in 1986 by Peters et al (1999) [42]. The 99m Tc-HMPAO
complex is able to enter the cell, transform to a hydrophilic state and then becomes trapped in the cell [23]. Some
advantages of using this tracer include low radiation burden, continuous availability, cheapness and ideal γ-ray energy
[43]. It also has a higher proton flux, which permits the imagining of body parts such as feet [23]. Given its low radiation,
this tracer can easily be used in children. However, this tracer is less stable than 111In-oxine, eluting from cells up to 7%/h,
which requires imaging to occur within 2-4h after injection of the tracer [23, 43, 44]. 99m Tc-HMPAO accumulated in the
gastrointestinal tract, bone marrow, spleen, liver and kidneys [23]. It is commonly used in the imaging of bone/joint
infection, irritable bowel disease and soft tissue infection.
Leukocyte labeling with 111In-oxine or 99m Tc-HMPAO
The reported accuracy of WBC-labeling combined with bone marrow imaging ranges from 86-98% of patients [39-41, 4554]. One of the earliest studies with 30 patients examining labeled leukocytes with bone marrow imaging and hip
arthroplasty by Mulamba et al. (1983) [38] observed a 92% sensitivity and 100% specificity for diagnosing hip infections.
Another study of labeled leukocytes and bone marrow scans in 72 patients with hip arthroplasty by Palestro et al. (1990)
[40] demonstrated 100% sensitivity and 97% specificity in diagnosing infection. A review examining 59 patients with failed
hip- and knee arthroplasties by Love at al. (2004) [53] reported the sensitivity, specificity and accuracy of combined
leukocyte/bone marrow scanning to be 100%, 91%, and 95%, respectively. In addition, a study by El Espera et al. (2004)
[52] determined 80% sensitivity, 94% specificity and 91% accuracy in 60 patients with knee or hip arthroplasty that
received combined leukocyte/bone marrow scanning. While most studies show that combined leukocyte-and bone
marrow scanning is highly specific, the sensitivity of this method can vary. A study by Pill et al. (2006) [55] reported only
50% sensitivity in combined leukocyte/bone marrow scan. Furthermore, while Joseph et al. (2001) [41] reported 100%
specificity in their patient population of 58 patients with total knee or hip arthroplasty, they observed only 46% sensitivity
for combined leukocyte/bone marrow imaging.
It has been argued that poor sensitivity can be attributed to chronicity of an infection, as well as non-specific
inflammation [29, 56-58]. While chronic infections are typically characterized by less distinct neutrophil recruitment and
edema [59], a study by Datz et al. (1986) [11] that examined the labeled leukocytes in acute and chronic infections found
no significant statistical difference in sensitivity. In non-specific inflammation, neutrophils are generally absent [60]. Given
that LS is most sensitive in imaging neutrophil-dominate responses [60], aseptic inflammation may lead to false negative
results and a decrease in sensitivity [61]. While it was once discussed that false negative results could be due to prior
antibiotic treatment, several studies have shown this not to be the case [62, 63]. However, one must keep in consideration
that both the activity and uptake can vary, as well as the normal distribution of WBC in the bone marrow [64]. For
example, one would expect to see fewer WBC migrating to the joints of chronic infection. Furthermore, uptake depends
on the number of WBC that migrate to the site of infection [64].
Despite the high accuracy of this technique, LS does have its disadvantages, which have to be considered
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before performing this test. Firstly, the procedure is labor intensive. Given that two to three technologists are involved in
the labeling and imaging processes, it can be estimated that a total of 8-10 hours is required from them for this technique,
over two days. Furthermore, this technique is routinely available in only a few hospitals worldwide. In addition, it involves
contact with blood products, which requires strict protocols, such as the use of a laminar flow hood [51, 53, 60, 65]. The
indications for the combination imaging LS/BMS include prosthetic joint infection, musculoskeletal infections, and
neuropathic joint [64]. Leukocyte scintigraphy has also been implemented in patients with fever of unknown origin,
postoperative infections, as well as systemic infections [64].
18

F-deoxyglucose (FDG)
The first studies investigating the role of 18F-FDG in infection imaging were first introduced in 2006 [66-68]. Cells with
increased glucose requirements, such as inflammatory cells and tumor cells readily take up 18F-FDG [43]. Given that
deoxyglucose cannot leave the cell after it has been taken up, it can be used in the imaging of the above-mentioned cells
[69, 70]. Some of the advantages of this tracer include easy preparation and imaging [43]. On the other hand,
disadvantages include a short half-time of 110 minutes, as well as a low labeling efficiency when compared to 111In-oxine
and 99mTc-HMPAO [59]. Given the negative aspects of the tracer, two to three times more activity must be used in the
labeling process, which ultimately results in a higher activity being injected into the patient [71]. In addition, given its short
half-life, late images required in prosthetic joint infection imaging are not possible [59]. Physiological uptake of 18F-FDG is
seen in the brain, heart, kidneys and bladder [59]. Infection imaging with 18F-FDG has shown high sensitivity, but low
specificity, mainly due to the fact that imaging is based on increased metabolic activity [72, 73]. Thus, its role in
diagnosing osteomyelitis and infected prosthetic joints is limited. One major drawback with 18F-FDG in infection imaging
are the artifacts adjacent to prostheses [74]. In addition, healing tissues up to 6 months following surgery, bone fractures,
varicose veins and atherosclerotic lesions can all demonstrate non-specific 18F-FDG uptake [75, 76]. As shown in a recent
study by Aydin et al. (2015) [77] 18F-FDG uptake was confined to the proximal segment of the prosthesis in 62
asymptomatic patients who underwent total hip replacement, whereby the femoral segment showed no uptake. Thus, a
positive 18F-FDG-scan in infection must be interpreted with caution given the various reasons that can produce false
positive results [78]. Several studies have investigated 18F-FDG in infection imaging. Zhuang et al. (2001) [79]
demonstrated 89.5% increase in 18F-FDG uptake along hip arthroplasties and 77.8% in knee arthroplasties. Chacko et al.
(2002) [80] exhibited 92% sensitivity and 97% specificity in infection of hip arthroplasty. In both of these studies, intensity
was not able to differentiate between aseptic inflammation versus infection. As seen in a study by Delank et al. (2006)
[81] they were able to demonstrate that 18F-FDG-PET was able to positively diagnose evidence of loosening in 76.4% of
patients and detect periprosthetic inflammation in 100% of septic cases. However, only 45.5% of cases were positive for
increased abrasion and aseptic inflammation, thus, 18F-FDG-PET was not able to deduce the difference between
abrasion-induced versus inflammation due to bacteria [81]. Similar results were seen in a study by Garcia-Barrecheguren
et al. (2007) [82] who reported a low sensitivity (64%) and specificity (67%) of 18F-FDG-PET in hip replacement infections.
In regards to accuracy, Cremerius et al. (2003) [83] and Gravius et al. (2010) [84] reported roughly 89% accurate in
infection of hip arthroplasties, while Manthey et al. (2002) reported 96% accuracy [85]. On the other hand, Stumpe et al.
(2004) [86] demonstrated an accuracy of only 69%, with bone scintigraphy being more accurate (80%) than 18F-FDG-PET
in their study. Pill et al. (2006) [55] exhibited 95% sensitivity and 93% specificity in infected hip replacements, versus 50%
sensitivity and 95.1% specificity of WBC/marrow imaging in a subgroup of these patients. Regardless of the different
criteria on how to interpret 18F-FDG uptake in infection, it has been exhibited in several studies that 18F-FDG-PET is less
accurate when compared to labeled WBC/bone marrow imaging in diagnosing prosthetic joint infection [53, 87, 88]. In a
meta-analysis, the overall sensitivity and specificity of 18F-FDG-PET in prosthetic joint infection was 82% and 87%,
respectively [89]. Thus, its role in diagnosing prosthetic joint infection still needs to be determined. However, it has been
shown to be important in diagnosing spondylodiscitis [79, 90, 91].

Future outlook
Recently published papers assessing future directions in leukocyte labeling include using monoclonal antibodies, SPETCT as an adjunct to scintigraphy, as well as 18F-FDG PET. The use of monoclonal antibodies such as Sulesomab for
infection diagnostics has also been recently discussed and reported sensitivity and specificity lie between 75% to 93%
and 65% to 86%, respectively [92-94]. Its role in infection diagnostics has, however, yet to be determined. On the other
hand, the additional role of SPET-CT is a promising direction in infection diagnostics. In a study by Graute et al. (2010)
[95] they were able to increase sensitivity from 66% to 89% and specificity from 60% to 73% by combining planar images
with SPET-CT. Furthermore, a recently published study by Kim et al. (2014) [96], which assessed adding SPET-CT to
99m
Tc-HMPAO-labeled leukocytes, demonstrated an increase in sensitivity from 82% to 93.3%, specificity 88% to 93.3%,
PPV from 89% to 94.3% and NPV 80.5% to 92.1% and diagnostic accuracy from 84.8% to 93.3%. Additionally, a study by
Bar-Shalom et al. (2006) [97] demonstrated the additional role of SPET/CT in patients with 111In-WBC, as it is able to
provide exact localization, as well as the extent of the infection, thus improving diagnosis. In addition, Filippi et al. (2006)
[98] demonstrated 100% accuracy when using SPET/CT with 99m Tc-exametazime labeled leukocytes in patients with
suspected musculoskeletal infection, compared to 64% when using solely scintigraphy. Horger et al. (2003) [99] exhibited
97% accuracy when using 99m Tc-labeled anti-granulocyte antibody and SPET/CT in the diagnosis of bone infection versus
59% accuracy of scintigraphy alone. It is believed, in accordance with other studies that the CT component increases the
sensitivity by precisely localizing the anatomical site of infection [98]. Lastly, the role of 18F-FDG PET has showed great
potential for infection diagnostics and for studying bone metabolism. A study by Sterner et al. (2007) [100] was able to
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demonstrate that the sensitivity, specificity and accuracy of 18F-FDG PET, 100%, 56%, and 71%, respectively, were
higher when compared to radiographs with 43%, 86%, and 64%, respectively, when assessing for aseptic loosening in 14
patients with painful knee arthroplasties. Kobayashi et al. (2011) [101] exhibited sensitivity 95%, specificity 88% and
overall accuracy 91% of 18F-PET in 49 patients following total hip arthroplasty with significant differences shown between
the maximum standardized uptake value (SUVmax) values for aseptic and septic loosening. Several studies by Ullmark et
al. (2012, 2013) [102, 103] demonstrated the promising role of 18F-FDG PET in analyzing bone formation. While SPET-CT
increases sensitivity through the CT component, an increase in sensitivity leads to a decrease in specificity. In conclusion,
until the roles of SPET-CT and 18F-FDG PET in diagnostic infection imaging can be determined, the combination of LS
with bone marrow imaging is an accurate technique in diagnosing prosthetic infections.

Conclusion
Nuclear medicine plays a vital role in diagnosing prosthetic joint infections. This review has shown that currently,
WBC/bone marrow imaging is the best available diagnostic imaging test. Newer imaging modalities, such as SPET-CT
may in the future, play a bigger role in diagnosing prosthetic joint infections, especially given that it can provide us with
important additional information, such as exact anatomical location. The roles of 18F-FDG PET and 18F-FDG PET/CT have
yet to be determined.
The authors declare that they have no conflicts of interest.

Bibliography
1. Gemmel F, Van den Wyngaert H, Love C et al. Prosthetic joint infections: radionuclide state-of-the-art imaging. Europ J Nucl Med Mol Imag
2012; 39(5): 892-909.
2. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med 2009; 39(1): 66-78.
3. Lazzeri E, Manca M, Molea N et al. Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in
orthopaedic patients. Europ J Nucl Med Mol Imag 1999; 26(6): 606-14.
4. Bauer TW, Parvizi J, Kobayashi N et al. Diagnosis of periprosthetic infection. J Bone Joint Surg Amer vol. 2006; 88(4): 869-82.
5. Love C, Tomas MB, Marwin SE et al. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21(5):
1229-38.
6. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351(16): 1645-54.
7. Zimmerli W. Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. Best Practice Res Clin Rheumatol 2006; 20(6):
1045-63.
8. Cataldo MA, Petrosillo N, Cipriani M et al. Prosthetic joint infection: recent developments in diagnosis and management. J Infection 2010;
61(6): 443-8.
9. Datz FL. Indium-111-labeled leukocytes for the detection of infection: current status. Semin Nucl Med 1994; 24(2): 92-109.
10. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. II. Particles. J Nucl Med 1976; 17(6):
488-92.
11. Datz FL, Thorne DA. Effect of chronicity of infection on the sensitivity of the In-111-labeled leukocyte scan. Am J Roentgenol 1986; 147(4):
809-12.
12. Krznaric E, Roo MD, Verbruggen A et al. Chronic osteomyelitis: diagnosis with technetium-99m-d, l-hexamethylpropylene amine oxime
labelled leucocytes. Europ J Nucl Med 1996; 23(7): 792-7.
13. Mader JT, Brown GL, Guckian JC, et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal
osteomyelitis in rabbits. J Infectious Dis 1980; 142(6): 915-22.
14. Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013; 95-B(11):
1450-2.
15. Glithero PR, Grigoris P, Harding LK et al. White cell scans and infected joint replacements. Failure to detect chronic infection. J Bone Joint
Surg Br 1993; 75(3): 371-4.
16. Brammen L, Holinka J, Windhager R et al. A retrospective analysis of the accuracy of radioactively labeled autologous leukocy tes in
patients with infected prosthetic joints. 2015 (inpreperation-reviewed).
17. Yuan K, Chen HL, Cui ZM. Diagnostic accuracy of C-reactive protein for periprosthetic joint infection: a meta-analysis. Surg Infect
(Larchmt) 2014; 15(5): 548-59.
18. Berbari E, Mabry T, Tsaras G et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and
meta-analysis. J Bone Joint Surg Am 2010; 92(11): 2102-9.
19. Claassen L, Radtke K, Ettinger M et al. Preoperative diagnostic for periprosthetic joint infection prior to total k nee revision arthroplasty.
Orthop Rev (Pavia) 2014; 6(3): 5437.
99m
20. Peters AM. The utility of [ Tc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24(2): 110-27.
21. Chianelli M, Mather SJ, Martin-Comin J et al. Radiopharmaceuticals for the study of inflammatory processes: a review. Nuclear medicine
communications 1997; 18(5): 437-55.
22. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol 2004; 32(2): 47-57; quiz 8-9.
99m
23. Hughes DK. Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-,
Tc-HMPAO-, and
99m
67
Tc-stannous fluoride colloid-labeled leukocytes and with Ga-citrate. J Nucl Med Technol 2003; 31(4):196-201; quiz 3-4.
24. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994; 24(2): 128-41.

www.nuclmed.gr

99

Hell J Nucl Med Suppl, September-December 2015

25. Williams F, McCall IW, Park WM et al. Gallium-67 scanning in the painful total hip replacement. Clin Radiol 1981; 32(4): 431-9.
26. Tehranzadeh J, Gubernick I, Blaha D. Prospective study of sequential technetium-99m phosphate and gallium imaging in painful hip
prostheses (comparison of diagnostic modalities). Clin Nucl Med 1988; 13(4): 229-36.
27. Gomez-Luzuriaga MA, Galan V, Villar JM. Scintigraphy with Tc, Ga and In in painful total hip prostheses. Int Orthop 1988; 12(2): 163-7.
99m
67
111
28. Mountford PJ, Hall FM, Wells CP et al.
Tc-MDP, Ga-citrate and
In-leucocytes for detecting prosthetic hip infection. Nucl Med
Commun 1986; 7(2): 113-20.
29. McKillop JH, McKay I, Cuthbert GF et al. Scintigraphic evaluation of the painful prosthetic joint: a comparison of gallium-67 citrate and
indium-111 labelled leucocyte imaging. Clin Radiol 1984; 35(3): 239-41.
30. Kraemer WJ, Saplys R, Waddell JP et al. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J
Arthroplasty 1993; 8(6): 611-6.
31. Aliabadi P, Tumeh SS, Weissman BN et al. Cemented total hip prosthesis: radiographic and scintigraphic evaluation. Radiology 1989;
173(1): 203-6.
32. Merkel KD, Brown ML, Fitzgerald RH, Jr. Sequential technetium-99m HMDP-gallium-67 citrate imaging for the evaluation of infection in the
painful prosthesis. J Nucl Med 1986; 27(9): 1413-7.
33. Merkel KD, Fitzgerald RH, Jr., Brown ML. Scintigraphic examination of total hip arthroplasty: comparison of indium with technetium-gallium
in the loose and infected canine arthroplasty. Hip 1984: 163-92.
34. Thakur ML, Lavender JP, Arnot RN, et al. Indium-111-labeled autologous leukocytes in man. J Nucl Med 1977; 18(10): 1014-21.
35. Pring DJ, Henderson RG, Keshavarzian A et al. Indium-granulocyte scanning in the painful prosthetic joint. Am J Roentgenol 1986; 147(1):
167-72.
36. Pring DJ, Henderson RG, Rivett AG et al. Autologous granulocyte scanning of painful prosthetic joints. J Bone Joint Surg Br 1986; 68(4):
647-52.
37. Wukich DK, Abreu SH, Callaghan JJ et al. Diagnosis of infection by preoperative scintigraphy with indium-labeled white blood cells. J Bone
Joint Surg Am 1987; 69(9): 1353-60.
38. Mulamba L, Ferrant A, Leners N et al. Indium-111 leucocyte scanning in the evaluation of painful hip arthroplasty. Acta Orthop Scand 1983;
54(5): 695-7.
39. Palestro CJ, Swyer AJ, Kim CK et al. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP
imaging. Radiology 1991; 179(3): 645-8.
40. Palestro CJ, Kim CK, Swyer AJ et al. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary
technetium-99m-sulfur colloid imaging in suspected infection. J Nucl Med 1990; 31(12): 1950-5.
41. Joseph TN, Mujtaba M, Chen AL et al. Efficacy of combined technetium-99m sulfur colloid/indium-111 leukocyte scans to detect infected
total hip and knee arthroplasties. J Arthroplasty 2001; 16(6): 753-8.
99m
42. Peters AM, Danpure HJ, Osman S et al. Clinical experience with
Tc-hexamethylpropylene-amineoxime for labelling leucocytes and
imaging inflammation. Lancet 1986; 2(8513): 946-9.
43. Corstens FH, van der Meer JW. Nuclear medicine's role in infection and inflammation. Lancet 1999; 354(9180): 765-70.
99m
44. Larikka MJ, Ahonen AK, Junila JA et al. Improved method for detecting knee replacement infections based on extended combi ned
Tcwhite blood cell/bone imaging. Nucl Med Commun 2001; 22(10): 1145-50.
45. King AD, Peters AM, Stuttle AW et al. Imaging of bone infection with labelled white blood cells: role of contemporaneous bone marrow
imaging. Europ J Nucl Med 1990; 17(3-4): 148-51.
46. Seabold JE, Nepola JV, Marsh JL et al. Postoperative bone marrow alterations: potential pitfalls in the diagnosis of osteomye litis with In111-labeled leukocyte scintigraphy. Radiology 1991; 180(3): 741-7.
47. Palestro CJ, Roumanas P, Swyer AJ et al. Diagnosis of musculoskeletal infection using combined In-111 labeled leukocyte and Tc-99m SC
marrow imaging. Clin Nucl Med 1992; 17(4): 269-73.
48. Achong DM, Oates E. The computer-generated bone marrow subtraction image: a valuable adjunct to combined In-111 WBC/Tc-99m in
sulfur colloid scintigraphy for musculoskeletal infection. Clin Nucl Med 1994; 19(3): 188-93.
49. Devillers A, Moisan A, Jean S et al. Technetium-99m hexamethylpropylene amine oxime leucocyte scintigraphy for the diagnosis of bone
and joint infections: a retrospective study in 116 patients. Europ J Nucl Med 1995; 22(4): 302-7.
50. Palestro CJ, Mehta HH, Patel M et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid
scintigraphy. J Nucl Med 1998; 39(2): 346-50.
51. Palestro CJ. Nuclear medicine, the painful prosthetic joint, and orthopedic infection. J Nucl Med 2003; 44(6): 927-9.
99m
111
52. El Espera I, Blondet C, Moullart V et al. The usefulness of
Tc sulfur colloid bone marrow scintigraphy combined with
In leucocyte
scintigraphy in prosthetic joint infection. Nucl Med Commun 2004; 25(2): 171-5.
18
53. Love C, Marwin SE, Tomas MB et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection F-FDG
111
99m
and In-labeled leukocyte/ Tc-sulfur colloid marrow imaging. J Nucl Med 2004; 45(11): 1864-71.
99m
54. Fuster D, Duch J, Soriano A et al. [Potential use of bone marrow scintigraphy in suspected prosthetic hip infection evaluated with
TcHMPAO-leukocytes]. Revista Espanola de Medicina Nuclear 2008; 27(6): 430-5.
55. Pill SG, Parvizi J, Tang PH et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell
imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty 2006; 21(6 Suppl 2): 91-7.
56. Propst-Proctor SL, Dillingham MF, McDougall IR et al. The white blood cell scan in orthopedics. Clin Orthop Related Res 1982; (168): 15765.
57. Johnson JA, Christie MJ, Sandler MP et al. Detection of occult infection following total joint arthroplasty using sequential technetium-99m
HDP bone scintigraphy and indium-111 WBC imaging. J Nucl Med 1988; 29(8): 1347-53.
58. Al-Sheikh W, Sfakianakis GN, Mnaymneh W et al. Subacute and chronic bone infections: diagnosis using In-111, Ga-67 and Tc-99m MDP
bone scintigraphy, and radiography. Radiology 1985; 155(2): 501-6.
59. Glaudemans AW, Galli F, Pacilio M et al. Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater 2013; 25: 61-77.
60. Palestro CJ. Nuclear medicine and the failed joint replacement: Past, present, and future. World J Radiol 2014; 6(7): 446-58.
61. Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: current status and future directions. Q uart J Nucl Med Mol Imag 2009;

www.nuclmed.gr

100

Hell J Nucl Med Suppl, September-December 2015

53(1): 105-23.
111
62. Sinzinger H, Granegger S. The effect of various antibiotics on the labelling efficiency of human white blood cells with
In-oxine. Nucl Med
Commun 1988; 9(8): 597-601.
63. Datz FL, Thorne DA. Effect of antibiotic therapy on the sensitivity of indium-111-labeled leukocyte scans. J Nucl Med 1986; 27(12): 1849-53.
64. Palestro CJ, Love C, Tronco GG et al. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing
musculoskeletal infection. Radiographics 2006; 26(3): 859-70.
65. Roca M, Martin-Comin J, Becker W et al. A consensus protocol for white blood cells labelling with technet ium-99m hexamethylpropylene
amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Europ J Nucl Med 1998; 25(7): 797-9.
18
66. Dumarey N, Egrise D, Blocklet D et al. Imaging infection with F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J J Nucl
Med 2006; 47(4): 625-32.
18
67. Rini JN, Palestro CJ. Imaging of infection and inflammation with F-FDG-labeled leukocytes. Quart J Nucl Med Mol Imaging 2006; 50(2):
143-6.
111
68. Rini JN, Bhargava KK, Tronco GG et al. PET with FDG-labeled leukocytes versus scintigraphy with
In-oxine-labeled leukocytes for
detection of infection. Radiology 2006; 238(3): 978-87.
69. Guhlmann A, Brecht-Krauss D, Suger G et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic
osteomyelitis. J Nucl Med 1998; 39(12): 2145-52.
70. Sugawara Y, Braun DK, Kison PV et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission
tomography: preliminary results. Europ J Nucl Med 1998; 25(9): 1238-43.
71. Palestro CJ, Love C, Miller TT. Diagnostic imaging tests and microbial infections. Cell Microbiol 2007; 9(10): 2323-33.
72. Kumar V. Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Q uart J Nucl Med Mol Imaging 2005;
49(4): 325-38.
73. Aksoy SY, Asa S, Ozhan M et al. FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. EuropJ Nucl Med Mol
Imaging 2014; 41(3): 556-64.
74. Goerres GW, Ziegler SI, Burger C et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003; 226(2):
577-84.
75. Zhuang H, Sam JW, Chacko TK et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Europ J Nucl
Med Mol Imaging 2003; 30(8): 1096-103.
76. Jones-Jackson L, Walker R, Purnell G et al. Early detection of bone infection and differentiation from post-surgical inflammation using 218
deoxy-2-[ F]-fluoro-D-glucose positron emission tomography (FDG-PET) in an animal model. J Orthop Res 2005; 23(6): 1484-9.
18
77. Aydin A, Yu JQ, Zhuang H et al. Patterns of F-FDG PET images in patients with uncomplicated total hip arthroplasty. Hell J Nucl Med
2015; 18(2): 93-6.
78. Israel O, Keidar Z. PET/CT imaging in infectious conditions. Ann N Y Acad Sci 2011; 1228: 150-66.
18
79. Zhuang H, Duarte PS, Pourdehnad M et al. The promising role of F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl
Med 2001; 42(1): 44-8.
80. Chacko TK, Zhuang H, Stevenson K et al. The importance of the location of fluorodeoxyglucose uptake in periprosthetic inf ection in painful
hip prostheses. Nucl Med Commun 2002; 23(9): 851-5.
18
81. Delank KS, Schmidt M, Michael JW et al. The implications of F-FDG PET for the diagnosis of endoprosthetic loosening and infection in
hip and knee arthroplasty: results from a prospective, blinded study. BMC Musculoskelet Disord 2006; 7: 20.
82. Garcia-Barrecheguren E, Rodriguez Fraile M, Toledo Santana G et al. [FDG-PET: a new diagnostic approach in hip prosthetic replacement].
Rev Esp Med Nucl 2007; 26(4): 208-20.
18
83. Cremerius U, Mumme T, Reinartz P et al. [Analysis of F-FDG uptake patterns in PET for diagnosis of septic and aseptic loosening after
total hip arthroplasty]. Nuklearmedizin 2003; 42(6): 234-9.
18
84. Gravius S, Gebhard M, Ackermann D et al. [Analysis of F-FDG uptake pattern in PET for diagnosis of aseptic loosening versus prosthesis
infection after total knee arthroplasty. A prospective pilot study]. Nuklearmedizin 2010; 49(3): 115-23.
18
85. Manthey N, Reinhard P, Moog F et al. The use of [ F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis,
loosening and infection of hip and knee prostheses. Nucl Med Commun 2002; 23(7): 645-53.
86. Stumpe KD, Notzli HP, Zanetti M et al. FDG PET for differentiation of infection and aseptic loosening in total hip replac ements: comparison
with conventional radiography and three-phase bone scintigraphy. Radiology 2004; 231(2): 333-41.
99m
87. Van Acker F, Nuyts J, Maes A et al. FDG-PET,
Tc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful
total knee arthroplasties. Europ J Nucl Med 2001; 28(10): 1496-504.
18
88. Vanquickenborne B, Maes A, Nuyts J et al. The value of ( F)FDG-PET for the detection of infected hip prosthesis. Europ J Nucl Med Mol
Imaging 2003; 30(5): 705-15.
89. Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Europ J Nucl Med Mol
Imaging 2008; 35(11): 2122-32.
90. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and
inflammation. Semin Nucl Med 2002; 32(1):4 7-59.
91. Bleeker-Rovers CP, de Kleijn EM, Corstens FH et al. Clinical value of FDG PET in patients with fever of unknown origin and patients
suspected of focal infection or inflammation. Europ J Nucl Med Mol Imaging 2004; 31(1): 29-37.
99m
92. Iyengar KP, Vinjamuri S. Role of
Tc Sulesomab in the diagnosis of prosthetic joint infections. Nucl Med Commun 2005; 26(6): 489-96.
99m
93. Pakos EE, Fotopoulos AD, Stafilas KS et al. Use of
Tc-sulesomab for the diagnosis of prosthesis infection after total joint arthroplasty. J
Internat Med Res 2007; 35(4): 474-81.
94. von Rothenburg T SM, Schaffstein J, Koester O, Schmid G. Imaging of infected total arthroplasty with Tc-99m-labeled antigranulocyte
antibody Fab'fragments. Clin Nucl Med 2004; 29: 548-51.
99m
95. Graute V, Feist M, Lehner S et al. Detection of low-grade prosthetic joint infections using
Tc-antigranulocyte SPECT/CT: initial clinical
results. Europ J Nucl Med Mol Imaging 2010; 37(9): 1751-9.
99m
96. Kim HO, Na SJ, Oh SJ et al. Usefulness of adding SPECT/CT to
Tc-hexamethylpropylene amine oxime (HMPAO)-labeled leukocyte

www.nuclmed.gr

101

Hell J Nucl Med Suppl, September-December 2015

imaging for diagnosing prosthetic joint infections. J Comput Assist Tomogr 2014; 38(2): 313-9.
67
111
97. Bar-Shalom R, Yefremov N, Guralnik L et al. SPECT/CT using Ga and In-labeled leukocyte scintigraphy for diagnosis of infection. J
Nucl Med 2006; 47(4): 587-94.
99m
98. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in
Tc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl
Med 2006; 47(12): 1908-13.
99. Horger M, Eschmann SM, Pfannenberg C et al. The value of SPET/CT in chronic osteomyelitis. Europ J Nucl Med Mol Imaging 2003;
30(12):1665-73.
18
100. Sterner T, Pink R, Freudenberg L et al. The role of [ F]fluoride positron emission tomography in the early detection of aseptic loosening of
total knee arthroplasty. Int J Surg 2007; 5(2): 99-104.
101. Kobayashi N, Inaba Y, Choe H et al. Use of F-18 fluoride PET to differentiate septic from aseptic loosening in total hip arthroplasty
patients. Clin Nucl Med 2011; 36(11): e156-61.
18
102. Ullmark G, Nilsson O, Maripuu E et al. Analysis of bone mineralization on uncemented femoral stems by [ F]-fluoride-PET: a randomized
clinical study of 16 hips in 8 patients. Acta Orthop 2013; 84(2): 138-44.
103. Ullmark G, Sorensen J, Nilsson O. Analysis of bone formation on porous and calcium phosphate-coated acetabular cups: a randomised
clinical [18F]fluoride PET study. Hip Int 2012; 22(2): 172-8.

Thessaloniki – Sunset

www.nuclmed.gr

102

Hell J Nucl Med Suppl, September-December 2015

